Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Ferrari

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Journal of Virology|October 1, 2020
Dengue Virus Targets Nrf2 for NS2B3-Mediated Degradation Leading to Enhanced Oxidative Stress and Viral ReplicationMatteo Ferrari, Alessandra Zevini, Enrico Palermo, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|September 2, 2021
Detailed dosimetry calculation for in-vitro experiments and its impact on clinical BNCTAna Mailén Dattoli Viegas, Ian Postuma, Silva Bortolussi, et al.
The Lancet. Microbe|November 4, 2022
Vaccination and protective immunity to SARS-CoV-2 omicron variants in people with immunodeficienciesAngalee Nadesalingam, Diego Cantoni, Ernest T Aguinam, et al.
Journal of Medical Virology|June 15, 2022
Human seasonal coronavirus neutralization and COVID-19 severityDavid A Wells, Diego Cantoni, Martin Mayora-Neto, et al.
The Lancet. Microbe|July 5, 2021
Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UKAngalee Nadesalingam, Diego Cantoni, David A Wells, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 22, 2017
Activation of Nrf2 Signaling Augments Vesicular Stomatitis Virus Oncolysis via Autophagy-Driven Suppression of Antiviral ImmunityDavid Olagnier, Rassin R Lababidi, Samar Bel Hadj, et al.
The Journal of Infection|May 19, 2026
A phase I, needle free, dose escalation clinical trial of pEVAC-PS, a candidate pan-Sarbecovirus VaccineAlasdair Ps Munro, Matteo Ferrari, Rebecca Kinsley, et al.
Frontiers in Immunology|March 25, 2022
Neutralisation Hierarchy of SARS-CoV-2 Variants of Concern Using Standardised, Quantitative Neutralisation Assays Reveals a Correlation With Disease Severity; Towards Deciphering Protective Antibody ThresholdsDiego Cantoni, Martin Mayora-Neto, Angalee Nadesalingam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 20, 2020
How to Handle Concomitant Asymptomatic Prosthetic Joints During an Episode of Hematogenous Periprosthetic Joint Infection, a Multicenter AnalysisMarjan Wouthuyzen-Bakker, Marine Sebillotte, Cédric Arvieux, et al.
Vaccines|August 6, 2021
Exploiting Pan Influenza A and Pan Influenza B Pseudotype Libraries for Efficient Vaccine Antigen SelectionJoanne Marie M Del Rosario, Kelly A S da Costa, Benedikt Asbach, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Journal of Virology|October 1, 2020
Dengue Virus Targets Nrf2 for NS2B3-Mediated Degradation Leading to Enhanced Oxidative Stress and Viral ReplicationMatteo Ferrari, Alessandra Zevini, Enrico Palermo, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|September 2, 2021
Detailed dosimetry calculation for in-vitro experiments and its impact on clinical BNCTAna Mailén Dattoli Viegas, Ian Postuma, Silva Bortolussi, et al.
The Lancet. Microbe|November 4, 2022
Vaccination and protective immunity to SARS-CoV-2 omicron variants in people with immunodeficienciesAngalee Nadesalingam, Diego Cantoni, Ernest T Aguinam, et al.
Journal of Medical Virology|June 15, 2022
Human seasonal coronavirus neutralization and COVID-19 severityDavid A Wells, Diego Cantoni, Martin Mayora-Neto, et al.
The Lancet. Microbe|July 5, 2021
Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UKAngalee Nadesalingam, Diego Cantoni, David A Wells, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 22, 2017
Activation of Nrf2 Signaling Augments Vesicular Stomatitis Virus Oncolysis via Autophagy-Driven Suppression of Antiviral ImmunityDavid Olagnier, Rassin R Lababidi, Samar Bel Hadj, et al.
The Journal of Infection|May 19, 2026
A phase I, needle free, dose escalation clinical trial of pEVAC-PS, a candidate pan-Sarbecovirus VaccineAlasdair Ps Munro, Matteo Ferrari, Rebecca Kinsley, et al.
Frontiers in Immunology|March 25, 2022
Neutralisation Hierarchy of SARS-CoV-2 Variants of Concern Using Standardised, Quantitative Neutralisation Assays Reveals a Correlation With Disease Severity; Towards Deciphering Protective Antibody ThresholdsDiego Cantoni, Martin Mayora-Neto, Angalee Nadesalingam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 20, 2020
How to Handle Concomitant Asymptomatic Prosthetic Joints During an Episode of Hematogenous Periprosthetic Joint Infection, a Multicenter AnalysisMarjan Wouthuyzen-Bakker, Marine Sebillotte, Cédric Arvieux, et al.
Vaccines|August 6, 2021
Exploiting Pan Influenza A and Pan Influenza B Pseudotype Libraries for Efficient Vaccine Antigen SelectionJoanne Marie M Del Rosario, Kelly A S da Costa, Benedikt Asbach, et al.
Pageof 9